1
TITLE: Risankizumab maintenance therapy results in sustained improvements in endoscopic outcomes in patients with moderate to severe Crohn's Disease: Post-hoc analysis from the phase 3 study FORTIFY  Full Text
AUTHORS: Irving, P. M.; Abreu, M.; Axler, J.; Gao, X.; Torres, J.; Neimark, E.; Song, A.; Wallace, K.; Kligys, K.; Berg, S.; Liao, X.; Panaccione, R.;
PUBLISHED: 2022, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 16
INDEXED IN: WOS